Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohort.
Muhammed Shiraz MoosaGary MaartensHannah GunterShaazia AllieMohamed Farouk ChughlayMashiko SetshediSean WassermanDavid F SteadKaren CohenPublished in: Southern African journal of HIV medicine (2022)
Rechallenge was successful in most of our cohort. Pyrazinamide rechallenge should be carefully considered.